Coronary Artery Disease
Dipyridamole
Platelet Aggregation Inhibitors
Warfarin

Dipyridamole

Dipyridamole is an antiplatelet agent commonly used for secondary stroke prevention and as an adjunct to warfarin therapy in patients with mechanical heart valves. The drug also helps in evaluating coronary artery disease during pharmacological stress testing. This activity reviews the mechanism of action, adverse effect profile, contraindications, drug interactions, and clinical toxicology of dipyridamole, emphasizing its value in preventing thromboembolic events and its role in stress testing. Additionally, it explores emerging evidence on the potential use of dipyridamole in reducing restenosis following coronary artery stenting. A comprehensive understanding of its complex pharmacology allows healthcare professionals to tailor therapy to individual patient needs. This activity provides interprofessional healthcare providers with essential knowledge and practical tools to optimize dipyridamole administration, thereby emphasizing their crucial role in delivering therapy safely and effectively. By integrating evidence-based guidance, the program equips clinicians to deliver individualized care, minimize risks, and improve patient outcomes during dipyridamole administration.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.